FDA Brief

Warning letters Biologics

FDA warning letter to

Namita A. Goyal, M.D.

Issued Oct 10, 2024Posted Oct 22, 2024Center for Biologics Evaluation and Research (CBER)

Clinical Investigator. We haven't summarized this letter yet. Read it on fda.gov.